BECKMAN COULTER GENOMICS INC. – Trademark Portfolio
Entity Type: 03
BECKMAN COULTER GENOMICS INC. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 1 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include SPRI. The owner is based in Beverly, MA.
500 Cummings Center, Suite 2450
Beverly, MA 01915
Showing of trademarks Trademarks
Trademark Classifications
BECKMAN COULTER GENOMICS INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does BECKMAN COULTER GENOMICS INC. have?
BECKMAN COULTER GENOMICS INC. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 cancelled.
What trademark classes does BECKMAN COULTER GENOMICS INC. file in?
BECKMAN COULTER GENOMICS INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 42 (Computer & Scientific), Class 44 (Medical Services). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are BECKMAN COULTER GENOMICS INC.'s most well-known trademarks?
BECKMAN COULTER GENOMICS INC.'s registered trademark portfolio includes well-known marks such as SPRI. These are among 1 currently registered trademark in the portfolio.
What is BECKMAN COULTER GENOMICS INC.'s trademark registration success rate?
BECKMAN COULTER GENOMICS INC. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.